If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

3 Oct 2017 07:00

RNS Number : 4601S
Electrocomponents PLC
03 October 2017
 

 

Electrocomponents plc has today issued a trading update ahead of publishing half-year results on 14 November 2017

 

Regions

Q1

Q2

H1 2018

 

Northern Europe

 

10%

 

13%

11%

Southern Europe

11%

12%

11%

Central Europe

11%

15%

13%

Total Europe

11%

13%

12%

Asia & Emerging Markets

18%

17%

17%

North America

16%

15%

16%

Group

13%

14%

13%

 

 

 

Our good start in Q1 has continued into Q2, as strong execution and a positive market backdrop combined to drive faster revenue growth and market share gains across all five of our regions.

· Revenue growth(1) of 13% in H1 to September 2017, with all five regions continuing to see double-digit underlying revenue growth.

o Continued strong momentum in eCommerce with 14% H1 revenue growth.

o An acceleration in growth for RS Pro, our own-brand business, in Q2 leading to growth of 10% in H1 revenue.

o Trading comparatives will toughen in H2 with underlying revenue growth(1) trends in the year to March 2017 of 2.1% in H1 and 7.5% in H2.

· We continue to make good progress on our initiatives to stabilise gross margin and now expect to see a modest improvement in gross margin for H1 compared to the previous year. We remain on track to deliver stable gross margins for the full year.

· We have invested in inventory during H1 to improve stock availability and support faster revenue growth and, as such, we expect to see a higher than normal weighting of cash flow to the second half of our year to March 2018.

· Given stronger than expected progress to date and some benefit from translational foreign exchange(2) we now expect half year headline profit before tax to be around £78m (H1 2017: £55.1m).

· We are taking advantage of the strong momentum in the business to increase investment in areas such as innovation and digital in H2 to support future growth. Consequently, we now expect to see a more even distribution of profits between H1 and H2 in the current financial year.

 

 

LEI: 549300KVXDURRKVW7R37

 

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Head of Investor Relations & Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

 

Tulchan Communications

020 73534200

 

Notes:

1) Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying sales growth/decline").

2) Our profits remain sensitive to movements in exchange rates on translation of overseas profits. Every 1 cent movement in Euro will have c. £1.2m impact on profits. Every 1 cent movement in US $ will have c. £0.4m impact on profits. We expect to see around £5m benefit to profits from sterling weakness upon translation of overseas profits during the first half using our H1 average exchange rate of 1.29 for dollar and 1.14 for euro. If 30 September rates were to persist for the balance of the year, we would see a benefit of around £5m upon translation of overseas profits for the full year. 

3) During H1, we saw an adverse impact from fewer trading days which negatively impacted revenues by around £16m. In the full year we expect around a £24m adverse impact upon revenues from fewer trading days.

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Tuesday 3rd October

UK Time:

08.00h call

Telephone number:

+44 (0) 1452 55 55 66

PIN:

90190149

Chairman:

Lindsley Ruth

Electrocomponents plc - Replay Dial in Instructions (available until Tuesday 10th October)

Telephone number:

+44 (0) 1452 55 00 00

PIN:

90190149

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUSSRBAARRAA
Date   Source Headline
7th Mar 20173:43 pmRNSDirector Declaration
1st Mar 201712:28 pmRNSTotal Voting Rights
15th Feb 20172:48 pmRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSTrading update
1st Feb 20172:15 pmRNSHolding(s) in Company
1st Feb 201710:37 amRNSBlock listing Interim Review
31st Jan 201710:33 amRNSTotal Voting Rights
23rd Jan 201711:59 amRNSHolding(s) in Company
13th Jan 20174:01 pmRNSNotice of trading update
3rd Jan 201711:41 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDirectorate Change
9th Dec 201610:28 amRNSHolding(s) in Company
1st Dec 201611:12 amRNSTotal Voting Rights
18th Nov 20167:00 amRNS2017 Half-year Financial Results
14th Nov 201612:37 pmRNSHolding(s) in Company
31st Oct 20161:37 pmRNSTotal Voting Rights
7th Oct 20163:47 pmRNSHolding(s) in Company
4th Oct 20161:25 pmRNSHolding(s) in Company
30th Sep 201610:12 amRNSTotal Voting Rights
15th Sep 20162:48 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSTrading Statement
12th Sep 20167:00 amRNSDirectorate Change
1st Sep 201610:19 amRNSTotal Voting Rights
1st Aug 20169:42 amRNSBlock listing Interim Review
29th Jul 20162:50 pmRNSDirector/PDMR Shareholding
29th Jul 201611:35 amRNSTotal Voting Rights
22nd Jul 20169:23 amRNSDirector/PDMR Shareholding
20th Jul 201612:43 pmRNSResult of AGM
20th Jul 20167:00 amRNSDirectorate Change
20th Jul 20167:00 amRNSTrading Statement
5th Jul 201612:06 pmRNSNotice of Trading Update
30th Jun 201611:28 amRNSTotal Voting Rights
27th Jun 201611:39 amRNSDirector/PDMR Shareholding
23rd Jun 20161:04 pmRNSDirector/PDMR Shareholding
20th Jun 201610:40 amRNSDirector/PDMR Shareholding
16th Jun 20169:44 amRNSAnnual Financial Report
31st May 201610:45 amRNSTotal Voting Rights
23rd May 201610:40 amRNSHolding(s) in Company
19th May 20167:00 amRNSFinal Results
29th Apr 201610:00 amRNSTotal Voting Rights
5th Apr 20167:00 amRNSTrading Update
1st Apr 20167:00 amRNSTotal Voting Rights
31st Mar 20167:00 amRNSDirectorate Change
29th Mar 201611:34 amRNSHolding(s) in Company
18th Mar 201612:03 pmRNSDirector/PDMR Shareholding
18th Mar 20169:53 amRNSNotice of trading update
14th Mar 201611:37 amRNSDirector/PDMR Shareholding
1st Mar 20169:22 amRNSTotal Voting Rights
10th Feb 20167:00 amRNSTrading Statement
1st Feb 201610:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.